Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gilles Boire

Showing results (21-30 of 124) with videos related to

Pageof 13
Sort By:
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 3, 2020
Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of boneElizabeth Stephens, Michèle Roy, Martine Bisson, et al.
Arthritis Care & Research|January 3, 2013
Predictors of pain for patients with early inflammatory polyarthritisPatricia L Dobkin, Aihua Liu, Michal Abrahamowicz, et al.
BMC Rheumatology|September 29, 2024
Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based dataMarina G Birck, Luck Lukusa, Denis Choquette, et al.
Arthritis Care & Research|July 10, 2010
Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodiesMarie-Caroline Guzian, Nathalie Carrier, Pierre Cossette, et al.
Rheumatology International|October 28, 2018
Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelinesJoanna E M Sale, Matthew Gray, Daniel Mancuso, et al.
Rheumatology Advances in Practice|July 21, 2025
Validation of the Coping with Health Injuries and Problems questionnaire in a longitudinal cohort with recent-onset RAZafer Akman, Gilles Boire, Nathalie Carrier, et al.
Rheumatology (Oxford, England)|November 19, 2013
Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohortTommy Choy, Vivian P Bykerk, Gilles Boire, et al.
Rheumatology (Oxford, England)|June 23, 2016
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis CohortCarol A Hitchon, Gilles Boire, Boulos Haraoui, et al.
The Journal of Rheumatology|September 4, 2012
Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH studyLonnie Pyne, Vivian P Bykerk, Gilles Boire, et al.
Rheumatology Advances in Practice|September 26, 2022
Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritisIsabelle Gaboury, Patricia L Dobkin, Françoise Gendron, et al.
Pageof 13

Showing results (21-30 of 124) with videos related to

Sort By:
Pageof 13
Biochimica Et Biophysica Acta. Molecular Basis of Disease|June 3, 2020
Osteoclast signaling-targeting miR-146a-3p and miR-155-5p are downregulated in Paget's disease of boneElizabeth Stephens, Michèle Roy, Martine Bisson, et al.
Arthritis Care & Research|January 3, 2013
Predictors of pain for patients with early inflammatory polyarthritisPatricia L Dobkin, Aihua Liu, Michal Abrahamowicz, et al.
BMC Rheumatology|September 29, 2024
Incidence of serious infection among etanercept and infliximab initiators: safety comparison between biosimilars and bio-originators with Canadian population-based dataMarina G Birck, Luck Lukusa, Denis Choquette, et al.
Arthritis Care & Research|July 10, 2010
Outcomes in recent-onset inflammatory polyarthritis differ according to initial titers, persistence over time, and specificity of the autoantibodiesMarie-Caroline Guzian, Nathalie Carrier, Pierre Cossette, et al.
Rheumatology International|October 28, 2018
Treatment recommendations based on fracture risk status are not consistently provided in osteoporosis guidelinesJoanna E M Sale, Matthew Gray, Daniel Mancuso, et al.
Rheumatology Advances in Practice|July 21, 2025
Validation of the Coping with Health Injuries and Problems questionnaire in a longitudinal cohort with recent-onset RAZafer Akman, Gilles Boire, Nathalie Carrier, et al.
Rheumatology (Oxford, England)|November 19, 2013
Physician global assessment at 3 months is strongly predictive of remission at 12 months in early rheumatoid arthritis: results from the CATCH cohortTommy Choy, Vivian P Bykerk, Gilles Boire, et al.
Rheumatology (Oxford, England)|June 23, 2016
Self-reported comorbidity is common in early inflammatory arthritis and associated with poorer function and worse arthritis disease outcomes: results from the Canadian Early Arthritis CohortCarol A Hitchon, Gilles Boire, Boulos Haraoui, et al.
The Journal of Rheumatology|September 4, 2012
Increasing treatment in early rheumatoid arthritis is not determined by the disease activity score but by physician global assessment: results from the CATCH studyLonnie Pyne, Vivian P Bykerk, Gilles Boire, et al.
Rheumatology Advances in Practice|September 26, 2022
Mindfulness-based stress reduction to improve depression, pain and high patient global assessment in controlled rheumatoid arthritisIsabelle Gaboury, Patricia L Dobkin, Françoise Gendron, et al.
Pageof 13